title: Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the margin.
abstract: This is the third Research Note addressing pharmacoeconomics in prescribing research, reflecting the increasing use of economic evaluation in drug purchasing decisions in a variety of settings. In this segment we provide an overview of the theoretical basis, practical application and methodological limitations of cost-effectiveness analysis (CEA).
authors.affiliation: Pharmaceutical Benefits Branch, Department of Health and Ageing, Canberra, ACT, Australia. ruth.lopert@health.gov.au
authors.forename: R
authors.initials: R
authors.lastname: Lopert
authors.forename: D L
authors.initials: DL
authors.lastname: Lang
authors.forename: S R
authors.initials: SR
authors.lastname: Hill
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods*; D003657:Decision Making; D016527:Drug Costs / Q000706:statistics & numerical data*; D004358:Drug Therapy / Q000191:economics*; D017850:Economics, Pharmaceutical; D006138:Guaiac / Q000191:economics
chemical_list: D006138:Guaiac